4.42
price down icon3.28%   -0.15
after-market Dopo l'orario di chiusura: 4.31 -0.11 -2.49%
loading

Aptevo Therapeutics Inc Azioni (APVO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
21.51%
4.044
3.328 3.633 3.103 3.643
Operating Income/Loss
22.23%
-7.61
-6.226 -6.48 -5.213 -6.024
Income/Loss From Continuing Operations Before Tax
21.68%
-7.549
-6.204 -6.408 -5.101 -5.883
Income/Loss From Continuing Operations After Tax
21.68%
-7.549
-6.204 -6.408 -5.101 -5.883
Net Income/Loss
21.68%
-7.549
-6.204 -6.408 -5.101 -5.883
Preferred Stock Dividends And Other Adjustments
1.479
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
448.54%
4.049
0.7381 1.4585 10.55 3.5199
Diluted Average Shares
448.54%
4.049
0.7381 1.4585 10.55 3.5199
Basic Earnings Per Share
73.45%
-2.23
-8.40 -4.39 -0.48 -1.67
Diluted Earnings Per Share
73.45%
-2.23
-8.40 -4.39 -0.48 -1.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
1.479
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):